Complete Revascularization (CR) Versus Culprit-Only Percutaneous Coronary Intervention (CO-PCI) in NSTE-ACS with
Kesar Prajapati1, Shanmukh Sai Pavan Lingamsetty2, Harshith Thyagaturu3
1Internal Medicine, Metropolitan Hospital Center, NYC Health + Hospital, New York, New York, USA.
Insights
Complete revascularization (CR) significantly reduces mortality and reinfarction in Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) patients with multivessel disease. This strategy is superior to culprit vessel only-Percutaneous Coronary Intervention (CO-PCI).
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Complete revascularization (CR) is proven effective in ST-Elevation Myocardial Infarction (STEMI).
- The benefit of CR versus culprit vessel only-Percutaneous Coronary Intervention (CO-PCI) in Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) with multivessel disease is not well-established.
- This meta-analysis addresses the optimal revascularization strategy in NSTE-ACS.
Purpose of the Study:
- To compare the efficacy of CR versus CO-PCI in NSTE-ACS patients with multivessel disease.
- To evaluate the impact of CR on mortality, myocardial reinfarction, and other adverse cardiovascular events.
Main Methods:
- A systematic literature search was conducted across PubMed, Embase, and Cochrane databases.
- Eleven studies involving 36,997 NSTE-ACS patients were included.
- A random-effects model was used for meta-analysis, calculating risk ratios (RR) and 95% confidence intervals (CI).
Main Results:
- CR significantly reduced all-cause mortality (RR: 0.66; 95% CI: 0.55 to 0.79).
- Myocardial reinfarction rates were lower with CR (RR: 0.57; 95% CI: 0.43 to 0.76).
- CR also led to a reduction in composite endpoints (RR: 0.72; 95% CI: 0.63 to 0.82) and repeat revascularization (RR: 0.60; 95% CI: 0.54 to 0.66).
Conclusions:
- Complete revascularization is associated with improved outcomes in NSTE-ACS patients with multivessel disease.
- CR demonstrates a significant reduction in all-cause mortality, recurrent myocardial infarction, composite outcomes, and the need for repeat revascularization compared to CO-PCI.
- These findings support CR as the preferred strategy in this patient population.
Objective:
Contemporary data have demonstrated that a complete revascularization (CR) strategy reduces adverse cardiovascular events compared with culprit vessel only-Percutaneous Coronary Intervention (CO-PCI) in ST Elevation Myocardial Infarction (STEMI). The optimal strategy of CR versus CO-PCI in Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) remains unclear and was the goal of this meta-analysis.
Methods:
A systematic search of PubMed, Embase, and Cochrane databases for English-language studies from inception till November 2024 comparing CR versus CO-PCI in NSTE-ACS patients with multi-vessel disease was performed. A meta-analysis was performed using a random-effects model to calculate the risk ratio (RR) and 95% confidence interval (CI). Primary outcomes were all-cause mortality and myocardial reinfarction.
Results:
Eleven studies with total 36,997 NSTE-ACS patients were included in study with mean follow up of 31.3 months. CR showed reduction in all-cause mortality (1,457 of 16,939) compared to CO-PCI (2126 of 16,939) (RR: 0.66; 95% CI: 0.55 to 0.79). Myocardial reinfarction occurred in 149 of 6404 in CR versus 248 of 6404 in CO-PCI group (RR:0.57; 95% CI: 0.43 to 0.76). Composite endpoint was noted in 299 of 2,129 patients from CR vs 418 of 2131 patients from CO- PCI (RR:0.72; 95% CI: 0.63 to 0.82). Repeat revascularization was noted in 504 of 5661 patients from CR versus 849 of 5663 in CO- PCI patients group (RR:0.60; 95% CI: 0.54 to 0.66).
Conclusion:
In NSTEMI and multivessel disease, CR reduces all-cause mortality, recurrent myocardial infarction, composite outcome, and repeat revascularization compared to CO-PCI.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care


